Get started
Author

Fatime Szalai

Observed institution: Semmelweis University
ORCID: 0009-0002-6129-6143
Observed ORCID: 0009-0002-6129-6143
OpenAlex ID: A5092956940
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
2024 · Dániel Sztankovics, Dorottya Moldvai, et al. · Pathology & Oncology Research · 7
PDF
Rictor—A Mediator of Progression and Metastasis in Lung Cancer
2024 · Fatime Szalai, Dániel Sztankovics, et al. · Cancers · 7
PDF
Comparison of molecular subtype composition between independent sets of primary and brain metastatic small cell lung carcinoma and matched samples
2024 · Dániel Sztankovics, Fatime Szalai, et al. · Lung Cancer · 6
PDF
GPNMB immunohistochemistry is a useful ancillary tool for the diagnosis of pulmonary lymphangioleiomyomatosis
2025 · Fatime Szalai, Judit Pápay, et al. · Histopathology · 5
PDF
Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression
2024 · Dániel Sztankovics, Fatime Szalai, et al. · European Journal of Cell Biology · 2
Spatial Tumor Engagement and Functionality of Memory CD8+ T Cells Predicts Progression-Free and Overall Survival in Advanced Non- Small Cell Lung Cancer
2026 · David Dora, Ildikó Krencz, et al. · Research Square
PDF
CD36 ‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems
2026 · Anna Sebestyén, Viktória Varga, et al. · FEBS Journal
3D bioprinted in vitro models in cancer metabolism research.
2026 · Zsófia Gábriel, Fatime Szalai, et al. · PubMed
From 2D to 3D Bioprinted In Vitro Breast Cancer Model: A Comparative Study of Proliferation, Tissue Structure, and mTOR Signaling
2026 · Dorottya Moldvai, Gábor Petővári, et al. · MedComm
TSC gene-associated lesions of the lung
2026 · Fatime Szalai, Ildiko Krencz, et al. · Human Pathology
POU2F3 is a Spatiotemporally Permanent Marker in Small Cell Lung Carcinoma
2025 · Ildikó Krencz, Dániel Sztankovics, et al. · Journal of Thoracic Oncology
[Effects of 3D tissue structure on drug sensitivity - 3D bioprinted tissue mimetic structures in cancer research].
2023 · Dorottya Moldvai, Dániel Sztankovics, et al. · PubMed
[he importance of mTOR hyperactivity and RICTOR amplification, and the associated targeted therapy possibilities in malignant tumours].
2023 · Fatime Szalai, Ildikó Krencz, et al. · PubMed
Works count: 13
Citation count: 27
H-index: 4
I10-index:
Year
Topic
Type